Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pregnancy and birth clues: what raises autism risk?

NCT ID NCT07818460

Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 16, 2026 · Updated 2 times

Summary

Researchers at Assiut University Children's Hospital are comparing children with autism to age- and sex-matched children without it, looking for antenatal, perinatal, and postnatal factors such as parental age, maternal infection, gestational diabetes, birth asphyxia, and family history. The study also follows children with autism for six months to track changes in autism severity and adaptive behavior. About 84 children aged 3 to 17 are expected to take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If researchers identify which pregnancy and birth factors track with autism, that could sharpen screening and early support for children at higher risk.
What could go wrong
This observational study cannot prove cause and effect, and its findings from one Egyptian hospital may not apply to other populations. Risk factors are complex and often overlap.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 84 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Children aged 3 to 17 years attending Assiut University Children's Hospital (Pediatric Neurology Unit).

Ages

3 to 17 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Inclusion Criteria (Cases): * Age 3 to 17 years * Confirmed diagnosis of ASD according to DSM-5 criteria, supported by standardized tools (e.g., CARS) * Parent or legal guardian able and willing to provide informed consent Inclusion Criteria (Controls): \- Age- and sex-matched children without ASD or other neurodevelopmental disorders Exclusion Criteria: * Age below 3 years or above 17 years * Known chromosomal or genetic syndrome associated with secondary autistic features (e.g., Fragile X, Down syndrome), unless studied as a separate subgroup * Incomplete medical records * Refusal of parents/guardians to participate * Loss to follow-up before the minimum 6-month prognostic assessment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism spectrum disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder pervasive developmental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autism spectrum disorder Autistic disorder Child development disorders, pervasive

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.